We are experts in DNA reconfiguration and will guide you through the best options for diversifying your systems, whether that’s using tried-and-trusted classical molecular biology techniques or pioneering state-of-the-art approaches that are nonetheless proven and predictable. Innovation is key at Ingenza, and vital to helping you accelerate successful commercialisation of new biological entities and bioprocesses.
— Professor George Hanna, Director, NIHR Diagnostic Evidence Co-operative and Head of Surgery, St. Mary’s Hospital, Paddington, London“Ingenza’s simple diagnostic assay for confirming nasogastric (NG) tube placement is an easy-to-implement and low cost option, providing a highly specific and sensitive test with the potential to reduce the number of expensive chest X-rays.”